Prescient Healthcare Group Acquires Strategic North

Acquisition to enhance depth, breadth and value of services offered to pharmaceutical and biotech clients of both organizations

Prescient, a biopharma product and portfolio strategy firm, announced Tuesday the recent acquisition of Strategic North, a global commercial strategy consultancy that partners with a wide range of pharmaceutical companies to help them better understand how their customers make decisions in order to unlock the full potential of their brands.